1081-P: Success of Curriculum-Based Online Education at Improving Knowledge, Competence, and Confidence Related to Staging and Managing Type 1 Diabetes

Introduction: The goal of continuing medical education (CME) is professional growth and improved patient care. We sought to determine if a curriculum of CME activities could improve the clinical knowledge, competence, and confidence of diabetologists/endocrinologists (D/Es), pediatricians and primary care physicians (PCPs) related to T1D. Methods: The educational curriculum consisted of 3 online activities, all of which used repeated pairs pre-/post-assessment study design and McNemar’s test (P .05 is considered significant) to assess educational effect. The activities launched from March to May, 2023, and data were collected for up to 12 weeks for each activity. Results: The education reached over 24,000 clinicians, including 1,600 D/Es, 1,700 pediatricians, and 2,900 PCPs. Overall, improvements were seen across all target audiences and in all topics, including overall relative improvements of 45% among D/Es, 60% among pediatricians, and 78% among PCPs. Additionally, the proportion of learners who demonstrated improvements/reinforcement of knowledge/competence, the education positively impacted 96% of D/Es, 89% of pediatricians, and 83% of PCPs. This resulted in significant improvements in confidence. Knowledge/competence improvement related to staging T1D: 118% D/Es, 152% pediatricians, and 179% PCPs (relative changes, all P.001). Knowledge/competence improvement related to treating T1D: 17% D/Es, 38% pediatricians, and 45% PCPs (relative changes, all P.001). Knowledge/competence improvement related to educating patients about T1D: 88% D/Es, 65% pediatricians, and 88% PCPs (relative changes, all P.001). Conclusion: This curriculum demonstrated success in educating on this topic, with significant increases in knowledge, competence, and confidence of clinicians related to staging, treating and educating patients about T1D. Disclosure A. Larkin: None. A. Le: None. Funding Developed through an independent educational grant from Provention Bio, a Sanofi Company.